Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: Effects of interferon gene transfer

Otolaryngology - Head and Neck Surgery

Volumn 120, Issue 5, 1999, Pages 665-671

  Arosarena, Oneida A ^a,b   Baranwal, Seema ^a,c   Strome, Scott ^a,b,f   Wolf, Gregory T ^a,b   Krauss, John C ^a,d   Bradford, Carol R ^a,b   Carey, Thomas E ^a,b,e  

^a University of Michigan ^*

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; GENE TRANSFER; GENETIC TRANSDUCTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOTHERAPY; RETROVIRUS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

EID: 0032938709     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1053/hn.1999.v120.a91770     Document Type: Article

References (17)

1. Mutlu S, Matthews JB, Midda M, et al. MHC antigen expression in human oral squamous carcinoma cell lines. J Pathol 1991;165:129-36.
2. Houck JR, Sexton FM, Zajdel G. HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1990;116:1181-5.
3. Prime SS, Pitigala-Arachchi A, Crane IJ, et al. The expression of cell surface MHC class I heavy and light chain molecules in premalignant and malignant lesions of the oral mucosa. Histopathology 1987;11:81-91.
4. Houck JR, Shah TP, Ohlsson-Wilhelm BM, et al. Modulation of human leukocyte antigen class I expression by gamma interferon in head and neck cancer cell lines. Am J Otolaryngol 1988;9:217-23.
5. Esteban F, Concha A, Delgado M, et al. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer 1990;62:1047-51.
6. Mattijssen V, de Mulder PHM, Schalwijk L, et al. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites. Int J Cancer 1991; Suppl 6:95-100.
7. Fisher PB, Rowley PT. Regulation of growth, differentiation and antigen expression in human tumor cells by recombinant cytokines: potential applications for the differentiation therapy of human cancer. Serono Symposia Publications from Raven Press 1991;82:201-13.
8. Strome SE, Krauss JC, Cameron MJ, et al. Immunobiologic effects of cytokine gene transfer of the B16-BL6 melanoma. Arch Otolaryngol Head Neck Surg 1993;119:1289-95.
9. Matthews JB, Pitigala-Arachchi A, Crane IJ, et al. The relationship between epithelial Ia expression and the inflammatory cell infiltrate during experimental oral carcinogenesis. Virchows Arch A Pathol Anat Histopathol 1988;413:521-8.
10. + T cells against the wild-type tumor: correlation with antigen presentation capability. J Exp Med 1992;175:1423-31.
11. Kelker W, van Dyke DL, Worsham MJ, et al. Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma. Anticancer Res 1996;16: 2365-72.
12. Frank CJ, McClatchey KD, Devaney KO, et al. Evidence that chromosome 18q is associated with tumor progression. Cancer Res 1997;57:824-7.
13. Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983;33:153-9.
14. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proceedings of the National Academy of Sciences of the United States 1988;85:6460-4.
15. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995;270:404-10.
16. Sacks PG, Taylor DL, Racz T, et al. A multicellular tumor spheroid model of cellular immunity against head and neck cancer. Cancer Immunol Immunother 1990;32:195-200.
17. Rabinowich H, Vitolo D, Altarac S, et al. Role of cytokines in adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. J Immunol 1992;149:340-9.